Prospective evaluation of an algorithm for the phenotypic screening of carbapenemase-producing Enterobacteriaceae

Journal of Antimicrobial Chemotherapy

Volumn 71, Issue 1, 2016, Pages 135-140

  Dortet, Laurent ^a,b,c   Cuzon, Gaelle ^a,b,c   Plésiat, Patrick ^d   Naas, Thierry ^a,b,c  

^a BICÊTRE HOSPITAL   (France)

^b Associated National Reference Center for Antibiotic Resistance   (France)

^c Associated French National Reference Center for Antibiotic Resistance: Carbapenemase producing Enterobacteriaceae   (France)

^d UNIVERSITY HOSPITAL OF BESANÇON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAPENEMASE; CLAVULANIC ACID; ERTAPENEM; IMIPENEM; MEROPENEM; TEMOCILLIN; TICARCILLIN; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; BETA LACTAM; BETA LACTAMASE;

ALGORITHM; ARTICLE; CARBAPENEMASE PRODUCING ENTEROBACTERIACEAE; CITROBACTER FREUNDII; DISK DIFFUSION; ENTEROBACTER AEROGENES; ENTEROBACTER CLOACAE; ESCHERICHIA COLI; KLEBSIELLA OXYTOCA; KLEBSIELLA PNEUMONIAE; NONHUMAN; PREDICTIVE VALUE; PROTEUS MIRABILIS; DRUG EFFECTS; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTION; ENZYMOLOGY; FRANCE; GENETICS; HUMAN; ISOLATION AND PURIFICATION; MASS SCREENING; MICROBIOLOGY; ORGANIZATION AND MANAGEMENT; PROCEDURES; PROSPECTIVE STUDY;

ALGORITHMS; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAMASES; BETA-LACTAMS; DISK DIFFUSION ANTIMICROBIAL TESTS; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; FRANCE; HUMANS; MASS SCREENING; PROSPECTIVE STUDIES;

EID: 84960087795     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkv308     Document Type: Article

References (20)

1. Nordmann P, Dortet L, Poirel L. Carbapenem resistance in Enterobacteriaceae: here is the storm!. Trends Mol Med 2012; 18: 263-72.
2. Nordmann P, Naas T, Poirel L. Global spread of carbapenemaseproducing Enterobacteriaceae. Emerg Infect Dis 2011; 17: 1791-8.
3. Munoz-Price LS, Poirel L, Bonomo RA et al. Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases. Lancet Infect Dis 2013; 13: 785-96.
4. Dortet L, Poirel L, Nordmann P. Worldwide dissemination of the NDM-type carbapenemases in Gram-negative bacteria. Biomed Res Int 2014; 2014: 249856.
5. Poirel L, Potron A, Nordmann P. OXA-48-like carbapenemases: the phantom menace. J Antimicrob Chemother 2012; 67: 1597-606.
6. Spellberg B, Blaser M, Guidos RJ et al. Combating antimicrobial resistance: policy recommendations to save lives. Clin Infect Dis 2011; 52 Suppl 5: S397-428.
7. Dortet L, Brechard L, Poirel L et al. Impact of the isolation medium for detection of carbapenemase-producing Enterobacteriaceae using an updated version of the Carba NP test. J Med Microbiol 2014; 63: 772-6.
8. Huang TD, Berhin C, Bogaerts P et al. Comparative evaluation of two chromogenic tests for rapid detection of carbapenemase in Enterobacteriaceae and in Pseudomonas aeruginosa isolates. J Clin Microbiol 2014; 52: 3060-3.
9. Nordmann P, Poirel L, Dortet L. Rapid detection of carbapenemaseproducing Enterobacteriaceae. Emerg Infect Dis 2012; 18: 1503-7.
10. Pasteran F, Veliz O, Ceriana P et al. Evaluation of the blue-carba test for rapid detection of carbapenemases in gram-negative bacilli. J Clin Microbiol 2015; 53: 1996-8.
11. Hrabak J, Chudackova E, Walkova R. Matrix-assisted laser desorption ionization-time of flight (MALDI-TOF) mass spectrometry for detection of antibiotic resistance mechanisms: from research to routine diagnosis. Clin Microbiol Rev 2013; 26: 103-14.
12. Findlay J, Hopkins KL, Meunier D et al. Evaluation of three commercial assays for rapid detection of genes encoding clinically relevant carbapenemases in cultured bacteria. J Antimicrob Chemother 2015; 70: 1338-42.
13. Clinical Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Twenty-fourth Informational Supplement M100-S24. CLSI, Wayne, PA, USA, 2014.
14. Dortet L, Brechard L, Cuzon G et al. Strategy for rapid detection of carbapenemase-producing Enterobacteriaceae. Antimicrob Agents Chemother 2014; 58: 2441-5.
15. Dortet L, Cuzon G, Nordmann P. Dissemination of carbapenemaseproducing Enterobacteriaceae in France, 2012. J Antimicrob Chemother 2014; 69: 623-7.
16. Komatsu Y, Murakami K, Nishikawa T. Penetration of moxalactam into its target proteins in Escherichia coli K-12: comparison of a highly moxalactam resistant mutant with its parent strain. Antimicrob Agents Chemother 1981; 20: 613-9.
17. Maurer FP, Castelberg C, Quiblier C et al. Evaluation of carbapenemase screening and confirmation tests with Enterobacteriaceae and development of a practical diagnostic algorithm. J Clin Microbiol 2015; 53: 95-104.
18. Nordmann P, Gniadkowski M, Giske CG et al. Identification and screening of carbapenemase-producing Enterobacteriaceae. Clin Microbiol Infect 2012; 18: 432-8.
19. Vading M, Samuelsen O, Haldorsen B et al. Comparison of disk diffusion, Etest and VITEK2 for detection of carbapenemase-producing Klebsiella pneumoniae with the EUCAST and CLSI breakpoint systems. Clin Microbiol Infect 2011; 17: 668-74.
20. Huang TD, Poirel L, Bogaerts P et al. Temocillin and piperacillin/tazobactam resistance by disc diffusion as antimicrobial surrogate markers for the detection of carbapenemase-producing Enterobacteriaceae in geographical areas with a high prevalence of OXA-48 producers. J Antimicrob Chemother 2014; 69: 445-50.